Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2014 Aug;6(4):302-4.
doi: 10.14740/jocmr1850w. Epub 2014 May 22.

Acute acalculous cholecystitis in patients with clear cell renal cell carcinoma treated with sunitinib: report of two cases

Affiliations
Case Reports

Acute acalculous cholecystitis in patients with clear cell renal cell carcinoma treated with sunitinib: report of two cases

Nobuki Furubayashi et al. J Clin Med Res. 2014 Aug.

Abstract

Although sunitinib is associated with a variety of adverse events, cases of sunitinib-related acute cholecystitis have rarely been reported. We herein report two cases of sunitinib-related acute acalculous cholecystitis in patients with clear cell renal cell carcinoma. In both cases, the gallbladder was surgically removed because it was difficult to improve the patient's condition with the cessation of sunitinib and non-surgical treatment only. Attention must be paid to the possibility of sunitinib-related acute cholecystitis, which, although uncommon, can be life-threatening.

Keywords: Acute acalculous cholecystitis; Adverse event; Cholecystectomy; Clear cell renal cell carcinoma; Sunitinib.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Abdominal computed tomography showed a tense and dilated gallbladder with surrounding fluid collection without gallbladder stones or emphysematous changes.
Figure 2
Figure 2
Abdominal ultrasonography revealed thickening of the gallbladder wall without gallbladder stones or emphysematous changes.
Figure 3
Figure 3
Thickened gallbladder wall in transmural lymphoeosinophilic inflammation with hemorrhage and necrotic change.

Similar articles

References

    1. Chow LQ, Eckhardt SG. Sunitinib: from rational design to clinical efficacy. J Clin Oncol. 2007;25(7):884–896. doi: 10.1200/JCO.2006.06.3602. - DOI - PubMed
    1. Thomas AA, Rini BI, Stephenson AJ, Garcia JA, Fergany A, Krishnamurthi V, Novick AC. et al. Surgical resection of renal cell carcinoma after targeted therapy. J Urol. 2009;182(3):881–886. doi: 10.1016/j.juro.2009.05.014. - DOI - PubMed
    1. de Lima Lopes G, Jr., Rocha Lima CM. Emphysematous cholecystitis in a patient with gastrointestinal stromal tumor treated with sunitinib. Pharmacotherapy. 2007;27(5):775–777. doi: 10.1592/phco.27.5.775. - DOI - PubMed
    1. Gomez-Abuin G, Karam AA, Mezzadri NA, Bas CA. Acalculous cholecystitis in a patient with metastatic renal cell carcinoma treated with sunitinib. Clin Genitourin Cancer. 2009;7(1):62–63. doi: 10.3816/CGC.2009.n.011. - DOI - PubMed
    1. Nakano K, Suzuki K, Morita T. Life-threatening acute acalculous cholecystitis in a patient with renal cell carcinoma treated by sunitinib: a case report. J Med Case Rep. 2012;6:69. - PMC - PubMed

Publication types

LinkOut - more resources